secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001493152-24-024960
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals increases authorized Series G Preferred shares from 8,950 to 12,826,273 for in-kind dividends
--------------------------------------------------------------------------------

- On June 17, 2024, MyMD filed a Certificate of Amendment to increase authorized Series G Convertible Preferred Stock from 8,950 to 12,826,273 shares.
- The amendment enables payment of dividends 'in kind' in the form of additional Preferred Stock shares, per Section 3 of the Certificate of Designations.
- The amendment was approved by Required Holders and became effective upon filing with the Delaware Secretary of State.
- The Company had previously entered into a Securities Purchase Agreement on May 20, 2024 for sale of Preferred Stock and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224024960/0001493152-24-024960-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224024960/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024960

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer